Section: Avian Bacteria

Avian Colibacillosis: A Comprehensive Guide to Escherichia coli Infection in Chickens

Introduction

Avian colibacillosis is a bacterial disease of poultry caused by avian pathogenic Escherichia coli (APEC). It is a leading cause of morbidity, mortality, and economic loss in the global poultry industry [1, 2]. The disease manifests as a spectrum of localized and systemic infections, including respiratory tract disease, septicemia, polyserositis, cellulitis, and omphalitis [2, 33]. APEC strains are a subset of extraintestinal pathogenic E. coli (ExPEC) that possess specific virulence traits enabling colonization and invasion of avian hosts [3, 34]. The question "does chicken have e coli" is answered affirmatively: E. coli is a normal inhabitant of the avian intestinal tract, but pathogenic strains can cause severe disease [4, 24]. Understanding the biology, epidemiology, and management of avian colibacillosis is essential for veterinary practitioners and poultry health professionals.

Etiology: Avian Pathogenic Escherichia coli

Avian colibacillosis is caused by APEC, a pathotype of E. coli that carries a distinct repertoire of virulence-associated genes (VAGs) [3, 5]. APEC strains typically belong to specific serogroups, with O1, O2, O8, O25, O78, O86, and O88 among the most frequently isolated from clinical cases [5, 6, 32]. The O78 serogroup is particularly prevalent and has been associated with major outbreaks [7, 6, 29]. Genotyping studies have identified sequence types (STs) such as ST117, ST23, ST73, and ST10 as common APEC lineages [7, 6, 34].

Virulence Factors

APEC pathogenicity is multifactorial, involving adhesins, iron acquisition systems, protectins, toxins, and biofilm formation [23, 32]. Key VAGs include:

  • Adhesins: Type 1 fimbriae (fimH), P fimbriae (pap), and S fimbriae (sfa) facilitate attachment to host epithelial cells [23, 34].
  • Iron acquisition: Genes such as iroN, iutA, and aerJ (associated with the CoIV plasmid) enable APEC to scavenge iron in the iron-restricted host environment [5, 32].
  • Protectins: The iss (increased serum survival) and ompT (outer membrane protease) genes confer resistance to complement-mediated killing [5, 32].
  • Toxins: Hemolysin (hlyF) and cytotoxic necrotizing factor (cnf1) contribute to tissue damage [32, 34].
  • Biofilm formation: Many APEC isolates produce biofilms, which enhance antimicrobial tolerance and persistence in the environment [8, 23].

The CoIV plasmid is a large conjugative plasmid that carries multiple VAGs and is frequently detected in APEC isolates from colibacillosis cases [5, 32]. Phylogenetic analysis places most APEC strains in phylogroups B2, D, and G, with B2 being predominant in some regions [5, 32, 35].

Epidemiology

Avian colibacillosis occurs worldwide and affects chickens of all ages, although young birds (1–14 days old) and layers at the onset of lay are most susceptible [2, 4]. The disease is often secondary to predisposing factors such as viral infections (e.g., infectious bronchitis virus, Newcastle disease virus), environmental stress, poor ventilation, and immunosuppression [2, 33].

Transmission

Transmission occurs via multiple routes. The primary source of APEC is chicken feces bacteria shed by infected or carrier birds [4, 24]. Fecal contamination of feed, water, litter, and equipment facilitates horizontal spread [2]. Vertical transmission through the egg (transovarian) is also documented, with APEC isolated from hatchery chicks and parent flocks [7, 6]. Airborne transmission via dust and aerosols contributes to respiratory infection [2]. The question "how does chicken get e coli" is thus answered by multiple pathways: ingestion, inhalation, and vertical transfer.

Prevalence and Outbreaks

Retrospective studies report colibacillosis prevalence rates of 13–100% depending on the population and diagnostic criteria [1, 4]. In Nigeria, 13.1% of cases presented to a veterinary teaching hospital over 11 years were diagnosed with colibacillosis [1]. In Georgia, USA, surveillance of broiler and layer flocks identified O78, O25, and O86 as dominant serogroups [5]. Major outbreaks in Finland in 2015 and 2021 were caused by clonal lineages ST117 O78:H4 and ST23 O78:H4, with evidence of spread through common parent flocks [6]. In Japan, CTX-M-55-type ESBL-producing fluoroquinolone-resistant O78-ST23 strains were repeatedly isolated from a single farm over two years, indicating persistence and clonal expansion [7].

Clinical Signs: Chicken E. coli Symptoms

The clinical presentation of avian colibacillosis varies with the age of the bird, the route of infection, and the virulence of the APEC strain. Chicken e coli symptoms can be acute or chronic.

Acute Form

Acute septicemia is characterized by sudden death, depression, anorexia, ruffled feathers, and cyanosis [2, 33]. Mortality can reach 30% or higher in untreated flocks [9]. In broilers, acute colibacillosis often follows respiratory infection, presenting with dyspnea, coughing, and rales [2].

Subacute and Chronic Forms

Subacute disease includes fibrinous pericarditis, perihepatitis, and airsacculitis (polyserositis) [2, 6]. Affected birds show reduced growth, poor feed conversion, and lameness due to femoral head necrosis [6]. In layers, colibacillosis causes a drop in egg production, egg peritonitis, and salpingitis [2, 30]. Omphalitis (yolk sac infection) occurs in chicks, with distended abdomen and unabsorbed yolk [2, 33].

Localized Infections

Cellulitis (inflammation of the subcutaneous tissue) is common in broilers, presenting as thickened, discolored skin over the abdomen and thighs [6]. Coligranuloma (Hjarre's disease) is a chronic form with granulomatous lesions in the liver, cecum, and duodenum [33].

Pathology

Gross lesions reflect the fibrinous and suppurative nature of APEC infection. Typical findings at necropsy include:

  • Pericarditis: Thickened, opaque pericardium with fibrinous exudate.
  • Perihepatitis: Fibrinous coating on the liver surface.
  • Airsacculitis: Cloudy, thickened air sacs with caseous exudate.
  • Omphalitis: Enlarged, discolored yolk sac with purulent material.
  • Cellulitis: Subcutaneous fibrinonecrotic plaques.
  • Femoral head necrosis: Separation of the femoral head from the shaft [6, 33].

Histopathology reveals fibrin deposition, heterophilic infiltration, and bacterial emboli in multiple organs [2, 10].

Diagnostics

Diagnosis of avian colibacillosis is based on clinical signs, gross pathology, and laboratory confirmation. Chicken feces bacteria can be cultured to detect APEC, but isolation from internal organs (liver, heart blood, bone marrow) is more specific for systemic infection [4, 6].

Bacteriological Culture

Samples are plated on MacConkey agar and eosin methylene blue (EMB) agar. E. coli appears as lactose-fermenting colonies on MacConkey and as green metallic sheen colonies on EMB [30]. Biochemical tests (indole, methyl red, Voges-Proskauer, citrate) confirm identification [23].

Serogrouping and Molecular Typing

Serogrouping using antisera or multiplex PCR (e.g., Klao9-SeroPCR) identifies common APEC serogroups [5]. Molecular typing includes detection of VAGs by PCR, phylogenetic grouping (Clermont triplex scheme), and multilocus sequence typing (MLST) [5, 6, 35]. Whole-genome sequencing (WGS) provides high-resolution epidemiological data [6, 25].

Antimicrobial Susceptibility Testing

Disk diffusion or broth microdilution methods (CLSI guidelines) determine resistance profiles [30]. Multidrug resistance (MDR) is common, with high resistance to ampicillin, tetracyclines, and sulfonamides [30, 32].

Differential Diagnosis

Avian colibacillosis must be differentiated from other bacterial infections such as salmonellosis, pasteurellosis (fowl cholera), and mycoplasmosis [2, 33]. Co-infections with Enterococcus faecalis can exacerbate disease severity [28].

Treatment: Chicken Bacterial Infection Treatment

Chicken bacterial infection treatment for colibacillosis historically relied on antibiotics, but rising antimicrobial resistance (AMR) has compromised efficacy [11, 12, 30]. Treatment should be guided by culture and sensitivity testing.

Antimicrobial Therapy

Commonly used antibiotics include amoxicillin, enrofloxacin, cefquinome, and florfenicol [12, 10, 9]. Cefquinome (a fourth-generation cephalosporin) administered intramuscularly at 2 mg/kg for three days reduced mortality and improved clinical signs in experimental infections [9]. However, resistance to fluoroquinolones and extended-spectrum beta-lactams is increasing [7, 30]. In Nepal, 100% of APEC isolates were resistant to ampicillin, and 86.4% to co-trimoxazole [30]. MDR was observed in 96% of isolates [30].

Alternative and Complementary Therapies

Due to AMR, alternative strategies are being investigated. Plant extracts and phytochemicals show promise:

  • Thymus vulgaris extract: Exhibits antibacterial activity (MIC 5.46–10.93 mg/ml), disrupts membranes, inhibits biofilm formation, and enhances ampicillin efficacy 4–8-fold [11].
  • Matrine and berberine hydrochloride: Synergistic effect against MDR APEC, reducing bacterial load and modulating inflammatory cytokines in vivo [12].
  • Schisandrin A: Ameliorates liver injury, reduces LPS levels, and restores tight junction proteins in infected chickens [10].
  • Caffeic acid-grafted chitosan loaded quercetin (CA-g-CS/QR): Disrupts bacterial cell walls and biofilms, and restores gut microbiota [13].
  • Ilex rotunda-Cyperus rotundus herb pair extract: Reduces mortality (30–45% vs. 60% in controls), inhibits pro-inflammatory cytokines, and remodels intestinal microbiota [14].

Probiotics and postbiotics also show potential. Solid-state fermentation products of Lactobacillus plantarum, Candida utilis, and Bacillus coagulans improved growth performance and reduced heart bacterial load in APEC-challenged broilers [15]. A postbiotic containing saponin, with or without vaccination, mitigated colibacillosis lesions [26].

Supportive Care

Supportive measures include ensuring adequate ventilation, reducing stocking density, and providing clean water and feed. Electrolytes and vitamins may aid recovery [2].

Control and Prevention

Control of avian colibacillosis requires an integrated approach combining biosecurity, management, vaccination, and prudent antimicrobial use.

Biosecurity and Management

Strict biosecurity measures reduce APEC introduction and spread. These include all-in-all-out production, cleaning and disinfection of houses, control of rodents and wild birds, and chlorination of drinking water [2, 33]. Reducing stress factors (e.g., ammonia levels, temperature fluctuations) is critical [2].

Vaccination

Vaccination is a key preventive tool. Several vaccine types have been developed:

  • Inactivated (bacterin) vaccines: Commercially available but often serotype-specific [16, 17].
  • Bivalent vaccines: Targeting both necrotic enteritis and colibacillosis [16].
  • Live attenuated vaccines: E.g., aroA mutants [33].
  • Bacterial ghosts: E. coli O78:K80 ghosts induced significant reduction in air sac lesions and elevated IFNγ, IgA, and IgY levels [29].
  • Membrane vesicle (MV) vaccines: MVs from LPS-low-expressed APEC strain FY26ΔmsbB provided cross-protection against multiple serogroups (O1, O7, O45, O78, O101) [18].
  • Nanovaccines: In ovo administration of trivalent inactivated nanovaccine was safe, induced antibody responses, and did not interfere with live viral vaccines [17].

Alternatives to Antibiotics

Phytogenic feed additives, probiotics, prebiotics, and organic acids are being explored to reduce APEC colonization and enhance immunity [11, 8, 15, 19, 14, 20, 10]. Zinc oxide nanoparticles synthesized by plant growth-promoting rhizobacteria showed strong antagonism against APEC [20].

Antimicrobial Stewardship

Prudent use of antibiotics, including avoidance of prophylactic use and adherence to withdrawal periods, is essential to slow AMR development [7, 9]. Monitoring resistance patterns on farms and hatcheries helps guide therapy [7, 30].

Diagnostic and Management Workflow

The following Mermaid diagram outlines a recommended diagnostic and management algorithm for suspected avian colibacillosis.

flowchart TD
    A[Clinical signs: depression, respiratory distress, mortality], > B[Necropsy]
    B, > C{Gross lesions?}
    C, >|Pericarditis, perihepatitis, airsacculitis| D[Collect liver, heart blood, bone marrow]
    C, >|Omphalitis, cellulitis| E[Collect yolk sac, subcutaneous tissue]
    D, > F[Bacteriological culture on MacConkey/EMB]
    E, > F
    F, > G[Lactose-fermenting colonies]
    G, > H[Biochemical identification: IMViC]
    H, > I[Antimicrobial susceptibility testing]
    I, > J[Serogrouping / PCR for VAGs]
    J, > K[Confirm APEC]
    K, > L[Implement treatment based on AST]
    L, > M[Biosecurity review and vaccination plan]
    M, > N[Monitor flock for recurrence]

Conclusion

Avian colibacillosis remains a formidable challenge to poultry health and production worldwide. The disease is caused by APEC, a diverse group of E. coli strains equipped with multiple virulence factors. Chicken e coli infection can manifest as acute septicemia or chronic polyserositis, leading to significant economic losses. Diagnosis relies on culture, serogrouping, and molecular characterization. Chicken bacterial infection treatment is increasingly complicated by AMR, necessitating alternative therapies such as phytochemicals, probiotics, and vaccines. Effective control requires a holistic approach encompassing biosecurity, vaccination, and antimicrobial stewardship. Ongoing surveillance of APEC serogroups and resistance patterns is essential to adapt control strategies [5, 6, 32].

References

[1] Orakpoghenor O. Avian Colibacillosis: A Review of Cases (2013 – 2023) Diagnosed at the Avian Clinic of the Veterinary Teaching Hospital, Ahmadu Bello University Zaria, Kaduna State, Nigeria. Collective Journal of Veterinary Science. 2025. URL: https://www.semanticscholar.org/paper/52dc577b06862c093579f84d3743c53d9d995ec8

[2] Gerasimova AO, Novikova OB, Savicheva AA. Avian colibacillosis – current aspects. Veterinary Science Today. 2023. URL: https://www.semanticscholar.org/paper/6709bc72aa3c2bf1242190d84494e86dd72e6dd

[3] Runcharoon K, Favro ME, Logue CM. The Pathogenicity Traits of Avian Pathogenic E. coli (APEC) O25-ST131 Associated with Avian Colibacillosis in Georgia Poultry and their Genotypic and Phenotypic Overlap with other ExPEC. Journal of Applied Microbiology. 2025. URL: https://www.semanticscholar.org/paper/526a4ae9b6ee6a697fdcc53cee7f9efae221c4a7

[4] Sani H, Iliyasu M, Alhaji S, et al. Virulence Phenotype of Avian Pathogenic Escherichia coli (APEC) and Prevalence of Colibacillosis among Poultry Birds in Bauchi Metropolis, Nigeria. International Journal of TROPICAL DISEASE & Health. 2025. URL: https://www.semanticscholar.org/paper/0ca4252ec4c16aeada1fdd887b6bf8ea19d73a47

[5] Runcharoon K, Favro ME, Logue CM. Longitudinal analysis of avian pathogenic Escherichia coli (APEC) serogroups and pathotypes from avian colibacillosis in Georgia: A continued investigation – year 2 analysis. Poultry Science. 2024. URL: https://www.semanticscholar.org/paper/5556a87e222933c469eaf19e835c587795ab2ea1

[6] Biström M, Vennerström P, Lienemann T, et al. Genomic epidemiology of avian pathogenic Escherichia coli in two broiler colibacillosis outbreaks in Finland. Veterinary Microbiology. 2025. URL: https://www.semanticscholar.org/paper/a0b7e4950f94115d7afba4ec0f37eb5994ac0d51

[7] Misumi W, Magome A, Okuhama E, et al. CTX-M-55-type ESBL-producing fluoroquinolone-resistant Escherichia coli sequence type 23 repeatedly caused avian colibacillosis in Kagoshima Prefecture, Japan. Journal of Global Antimicrobial Resistance. 2023. URL: https://www.semanticscholar.org/paper/c0bb4f10fc57fc5fa479936d11341b736693abe7

[8] Sutormina L, Samoilova Z, Smirnova G, et al. Effect of Medicinal Plant Extracts on Biofilm Formation in Escherichia Coli Strains Causing Avian Colibacillosis. Journal of Innovative Solutions for Eco-Environmental Sustainability. 2025. URL: https://www.semanticscholar.org/paper/9d06a513ccfaa4467e9bdfa4ce516a5f6fb0e704

[9] El-Tahawy AO, Said AA, Shams G, et al. Evaluation of cefquinome's efficacy in controlling avian colibacillosis and detection of its residues using high performance liquid chromatography (HPLC). Saudi Journal of Biological Sciences. 2022. URL: https://www.semanticscholar.org/paper/454648758571a35bb11dbde7b6f0d27a59e80272

[10] Bao J, Zhang Y, Zhang L, et al. Therapeutic effect of Schisandrin A on avian colibacillosis through gut-liver axis. Poultry Science. 2021. URL: https://www.semanticscholar.org/paper/ce184595cbae250e0bdf2edb37515575ec2f41b6

[11] Saci S, Nabti E, Sebbane H, et al. Exploring Thymus vulgaris Extract as a Phytotherapeutic Agent: A Multifaceted Approach to tackle Avian Colibacillosis and Drug Resistance. Poultry Science. 2025. URL: https://www.semanticscholar.org/paper/e162b0ccfc25ce13e4dfd050be9b31163ab48c8d

[12] Meng J, Wang W, Ding J, et al. The synergy effect of matrine and berberine hydrochloride on treating colibacillosis caused by an avian highly pathogenic multidrug-resistant Escherichia coli. Poultry Science. 2024. URL: https://www.semanticscholar.org/paper/91e809783baa48b5e0c48353ae279f695e3afec9

[13] Ren X, Yuan S, Ren J, et al. Effect of caffeic acid grafted chitosan loaded quercetin lyophilized powder formulation on avian colibacillosis and tissue distribution. Frontiers in Veterinary Science. 2024. URL: https://www.semanticscholar.org/paper/4741487f4ffbdeacf6b5af4dbc55528b1058cb83

[14] Liu H, Yang A, Wei X, et al. Preventive effects and underlying mechanisms of Ilex rotunda Thunb.-Cyperus rotundus L. herb pair extract on avian colibacillosis in chickens. Poultry Science. 2026. URL: https://www.semanticscholar.org/paper/964db70021440e62ddd0904c16f38d4629440d91

[15] Li F, Lv B, Zuo J, et al. Effect of Solid-State Fermentation Products of Lactobacillus plantarum, Candida utilis, and Bacillus coagulans on Growth Performance of Broilers and Prevention of Avian Colibacillosis. Veterinary Sciences. 2024. URL: https://www.semanticscholar.org/paper/8baf7bca6863d2e2451b03d272adf1de0ccdfc22

[16] Indrawati A, Safika S, Nugroho C, et al. Development and Evaluation of a Bivalent Oil-Adjuvanted Vaccine Against Necrotic Enteritis and Avian Colibacillosis in Poultry. Advances in Animal and Veterinary Sciences. 2025. URL: https://www.semanticscholar.org/paper/ae70af3a78c87f31edd8e066da29ef06de35015f

[17] Scuotto A, Ogonczyk-Makowska D, Magnez R, et al. Safety, Immunogenicity, and Vaccine Compatibility of a Trivalent Inactivated In Ovo Nanovaccine Against Avian Colibacillosis in Broilers Under Commercial Hatchery Conditions. Animals. 2026. URL: https://www.semanticscholar.org/paper/b0de0f51d7f846defa4872a31d883634d2acdf

[18] Zhu D, Zhang Y, Wang Z, et al. Exploiting membrane vesicles derived from avian pathogenic Escherichia coli as a cross-protective subunit vaccine candidate against avian colibacillosis. Poultry Science. 2024. URL: https://www.semanticscholar.org/paper/10a81e6ab315944c7e7ac5b02fb303a64ecc9111

[19] Kamil M, Abu-Bakar L, Reduan MHF, et al. The Use of Medicinal Plants in Avian Colibacillosis Management: A Review. Veterinary Integrative Sciences. 2023. URL: https://www.semanticscholar.org/paper/9f36e63c7f99602025d53aaeda187fe213f6fc6b

[20] Masood K, Yasmin H, Batool S, et al. A strategy for mitigating avian colibacillosis disease using plant growth promoting rhizobacteria and green synthesized zinc oxide nanoparticles. Saudi Journal of Biological Sciences. 2021. URL: https://www.semanticscholar.org/paper/7713900427f97f63e728760ad420fb70b3e23ed3

[21] Joseph J, Magee C, Jia L, et al. Phenotypic virulence characterization of avian pathogenic Escherichia coli (APEC) isolates from broiler breeders with colibacillosis in Mississippi. Journal of Applied Microbiology. 2024. URL: https://www.semanticscholar.org/paper/5f9078cb6de45f3eb5f8f479c0d8bc99a150e746

[22] Meena PR, Priyanka, Hemlata, et al. Poultry‐origin extraintestinal Escherichia coli strains carrying the traits associated with urinary tract infection, sepsis, meningitis and avian colibacillosis in India. Journal of Applied Microbiology. 2020. URL: https://www.semanticsch